BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 37 filers reported holding BIND THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $44,000 | -2.2% | 19,809 | 0.0% | 0.00% | – |
| Q4 2015 | $45,000 | -48.9% | 19,809 | 0.0% | 0.00% | – |
| Q3 2015 | $88,000 | -46.3% | 19,809 | -32.4% | 0.00% | – |
| Q2 2015 | $164,000 | +67.3% | 29,295 | +64.4% | 0.00% | – |
| Q1 2015 | $98,000 | -86.0% | 17,816 | -66.4% | 0.00% | – |
| Q2 2014 | $699,000 | -13.7% | 53,083 | -21.6% | 0.00% | – |
| Q1 2014 | $810,000 | -28.4% | 67,699 | -9.8% | 0.00% | – |
| Q4 2013 | $1,132,000 | – | 75,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 155,000 | $2,123,500,000 | 1.67% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,207 | $8,426,000 | 0.50% |
| BVF INC/IL | 150,000 | $2,264,000 | 0.40% |
| EMERALD ADVISERS, LLC | 419,752 | $6,334,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,384 | $3,869,000 | 0.20% |
| Alyeska Investment Group, L.P. | 62,087 | $937,000 | 0.04% |
| THOMPSON DAVIS & CO., INC. | 1,500 | $23,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 13,000 | $196,000 | 0.03% |
| SSI INVESTMENT MANAGEMENT LLC | 23,580 | $356,000 | 0.03% |
| TFS CAPITAL LLC | 20,933 | $316,000 | 0.02% |